Trelibet
Piberaline fumarate (EGYT-475, Trelibet) is a piperazine derivative drug invented in the 1980s. It has stimulant and antidepressant effects which are thought to be due largely to its active metabolite benzylpiperazine. [1] It was researched to a limited extent in Hungary and Spain, but was not widely accepted and does not seem to be in current use, although a closely related drug Befuraline with similar effects has been slightly more successful.
1-(Phenylmethyl)-4-(2-pyridinylcarbonyl)piperazine
CAS# 39640-14-7; 70062-37-2
References
- ↑ Tekes K, Tothfalusi L, Malomvolgyi B, Herman F, Magyar K. Studies on the biochemical mode of action of EGYT-475, a new antidepressant. Polish Journal of Pharmacology and Pharmacy. 1987 Mar-Apr;39(2):203-11.